Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

Helicobacter-induced gastric inflammation alters the properties of gastric tissue stem/progenitor cells

  • 1, 2,
  • 1,
  • 1, 3,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 1 and
  • 1Email author
BMC GastroenterologyBMC series – open, inclusive and trusted201717:145

https://doi.org/10.1186/s12876-017-0706-6

  • Received: 16 November 2016
  • Accepted: 24 November 2017
  • Published:

The Correction to this article has been published in BMC Gastroenterology 2018 18:4

Open Peer Review reports

Abstract

Background

Although Helicobacter-induced gastric inflammation is the major predisposing factor for gastric carcinogenesis, the precise mechanism by which chronic gastritis causes gastric cancer remains unclear. Intestinal and spasmolytic polypeptide-expressing metaplasia (SPEM) is considered as precancerous lesions, changes in epithelial tissue stem/progenitor cells after chronic inflammation has not been clarified yet. In this study, we utilized three-dimensional gastric epithelial cell culture systems that could form organoids, mimicking gastric epithelial layer, and characterized the changes in epithelial cells after chronic Helicobacter felis infection.

Methods

We used three mice model; 1) long-term H. felis infection, 2) H. felis eradication, and 3) MNU chemical carcinogenesis model. We performed cRNA microarray analysis after organoid culture, and analyzed the effects of chronic gastric inflammation on tissue stem cells, by the size of organoid, mRNA expression profile and immunohistochemical analysis.

Results

The number of organoids cultured from gastric epithelial cells was significantly higher in organoids isolated from H. felis-infected mice compared with those from uninfected gastric mucosa. Based on the mRNA expression profile, we found that possible stem cell markers such as Cd44, Dclk1, and genes associated with the intestinal phenotype, such as Villin, were increased in organoids isolated from H. felis-infected mucosa compared with the control. The upregulation of these genes were cancelled after H. felis eradication. In a xenograft model, tumors were generated only from organoids cultured from carcinogen-treated gastric mucosa, not from H. felis infected mucosa or control organoids.

Conclusions

Our results suggested that, as a possible mechanism of gastric carcinogenesis, chronic inflammation induced by H. felis infection increased the number of tissue stem/progenitor cells and the expression of stem cell markers. These findings suggest that chronic inflammation may alter the direction of differentiation toward undifferentiated state and that drawbacks may enable cells to redifferentiate to intestinal metaplasia or neoplasia.

Keywords

  • Helicobacter
  • Organoid
  • Intestinal metaplasia
  • SPEM; Spasmolytic polypeptide-expressing metaplasia
  • Cancer

Background

Gastric inflammation induced by CagA-positive Helicobacter infection is the major predisposing factor for gastric carcinogenesis [14]. Although the eradication of Helicobacter pylori (H. pylori) can reduce the risk of gastric cancer [57], considerable number of cancer has been found even after H. pylori eradication. Presence of certain type of metaplasia has been considered as the precursor of cancer cells and is associated with the risk of gastric cancer in human and mice [811]. Two types of metaplasia, are considered to be associated with gastric carcinogenesis in humans; intestinal metaplasia showed Muc2-positive intestinal goblet cells, whereas spasmolytic polypeptide-expressing metaplasia (SPEM) characterized TFF2-positive metaplasia through the transdifferetiation of chief cells [12]. In mouse model, chronic Helicobacter infection demonstrates only SPEM without progressing into intestinal metaplasia, but SPEM began to express intestinal phenotype after the long-term chronic inflammation [13].

Recently, a cancer stem/initiating cell concept was proposed to explain cancer development [14], and targeting cancer stem/initiating cells is a novel cancer-treatment strategy [15]. The cell surface marker CD44 is expressed in gastric cancer cells, and targeting of which may eliminate cancer cells resistant to radiation or chemotherapy [1618]. Although the origin of cancer cells remains debated, cancer stem/initiating cells might be derived from tissue stem/progenitor cells due to the similar characteristics of both cells [19]. Lineage tracing studies have demonstrated several markers, such as Villin, Lgr5, Sox2, or Troy as candidate stem cell markers [2024]. However, whether these markers could also cause gastric metaplasia, or gastric cancer, and also function as markers of stem cells in stomach remains to be elucidated.

To analyze the effects of chronic gastric inflammation on tissue stem cells and to examine the relationship between stem cells and carcinogenesis, we applied 3D gastric organoid culture systems, by which we could characterize the primary epithelial cells in vitro, tracking those cells for a long period of time and characterizing their properties without considering other interstitial cells [22, 2527]. Here, we presented comprehensive molecular characteristics of gastric epithelial cells following chronic inflammation by using gastric organoid culture system combined with in vivo study, and showed that chronic inflammation induced by Helicobacter infection increased the number of tissue stem/progenitor cells, which acquired intestinal properties, and would contribute to gastric carcinogenesis.

Methods

Mouse model

This research was approved by Institutional Animal Experiment Committee at Yokohama City University (Approved#; F-A-14-043). C57BL6/J wild-type mice were obtained from CLEA Japan Inc. (Tokyo, Japan). Male mice aged ≥8 weeks were used in the chronic gastritis model induced by Helicobacter infection [28]. Mice were sacrificed at 3, 6, and 12-month post infection, and the stomachs were removed and subjected to histological analysis or mRNA expression analysis (n = 5 per each time point, Model 1 in Fig. 1a). For eradication study (Model 2 in Fig. 1a), we used 5 mice as continuous infected group and 5 mice as eradicated group. Gastric epithelial cells from corpus area were used for organoid culture unless otherwise indicated [22]. We further investigated the tumorigenic activity of the organoids from Helicobacter-infected or chemical carcinogen N-methyl-N-nitroso-urea (MNU)-treated mucosa by injecting them into immune-deficient NOD/SCID (NOD.CB17-Prkdc scid /J) mice purchased from Charles River Laboratories International, Inc. (Wilmington, MA, USA) (n = 4 per group). In MNU model, male 6-week-old wild-type mice were treated with water containing 240 ppm MNU (Sigma, St. Louis, MO, USA) in alternate weeks for a total of 5 weeks, as described previously [29]. Mice were sacrificed at 4 weeks after the final MNU dosing, and then isolated gastric epithelial cells from antrum area for subsequent organoid culture (Model 3 in Fig. 1a). Because MNU is a chemical carcinogen in the mouse gastric antrum, we used this model as a positive control to assess tumorigenicity. We first performed 3D organoid culture as described above, from mice either infected with H. felis, treated with MNU, or untreated control (Model 1 and 3 in Fig. 1a). After 4 days of culture, each group of organoids was injected subcutaneously into mice and the tumorigenicity and histological changes were analyzed after 2 months.
Fig. 1
Fig. 1

Increased expression of known gastric tissue stem/progenitor markers. a Schema of experimental model used in current study. b Representative photographs of hematoxylin and eosin (H&E) staining and immunohistochemical analyses of TFF2, MUC2, CD44, DCLK1, and VILLIN in stomachs infected with Helicobacter felis and uninfected control (original magnification, ×200, scale bar; 100 μm). c The number of positive cells for each antibody per gland

Infection and eradication of H. felis

We used Helicobacter felis (H. felis, strain ATCC 49179) [30]. In brief, H. felis was cultured in trypticase soy broth at a titer of 1 × 107 CFU/ml. The bacterial suspension was stored at −80 degree until use. 10 wild-type male mice aged 8 weeks were infected with 0.25 ml of H. felis (concentration; 1.0 × 107 CFU/ml) suspension by oral gavage 3 times in a week. Four months after H. felis infection, mice were divided into two groups (5 mice each): one for continuous infection (Model 1 in Fig. 1) and the other for which H. felis was eradicated 2 months before sacrifice (Model 2 in Fig. 1) using a cocktail of antibiotics with tetracycline HCl (0.5 mg/30 g mouse/day), metronidazole (0.675 mg per 30 g mouse/day), and bismuth subsalicylate (0.185 mg per 30 g mouse/day) dissolved or suspended in a total volume of 500 μL sterile water, as described previously [31]. The cocktail was administered orally 5 days a week for 14 days. Eradication of H. felis was confirmed by histopathology and real-time PCR for H. felis flaB gene using gastric specimens as described previously [31]. We used 4 mice of 12 months’ post infection to analyze cRNA expression by microarray, and total 15 mice for immunohistochemical study (5 mice at 3 months, 5 mice at 6 months, and 5 mice at 12 months). Appropriate number of uninfected mice was used as experimental controls.

3-dimentional organoid culture of gastric epithelial cells

We cultured gastric epithelial cells in Matrigel in serum-free media for 3D organoid culture as described previously [32, 33]. Briefly, mouse gastric corpus was removed and cut into approximately 1-mm2 pieces. The gastric epithelial tissues were washed in ice-cold phosphate-buffered saline (PBS) three times. Next, the tissues were incubated in ice-cold PBS containing 10 mM EDTA at 4 °C for 3 h. After incubation, the tissue samples in PBS were vigorously shaken and centrifuged, and then the sediments were enriched in gastric glands for subsequent experiments. Isolated gastric glands were seeded on pre-warmed Matrigel plates (24 wells) supplemented with B27, N2, N-acetylcysteine (final 0.5 mM, Invitrogen, Carlsbad, CA, USA), and gastrin (10 nM; Sigma-Aldrich) containing growth factors (50 ng/ml epidermal growth factor [Peprotech, Rocky Hill, NJ, USA], 1 mg/ml R-spondin1, 100 ng/ml noggin [Peprotech], 100 ng/ml fibroblast growth factor 10 [Peprotech] and 100 ng/ml Wnt3A [R&D Systems, Minneapolis, MN, USA]) without using any feeder cells as described [22]. To exclude the effect of bacterial/fungal contamination to the organoid phenotype, we used Penicillin-streptomycin (100×; Invitrogen, cat. no. 15140–122) in organoid growth media. In the cytokine experiments, after isolating organoids from uninfected wild-type mice stomachs, we added either tumor necrosis factor (TNF)-α (10 ng/ml) or interleukin (IL)-1β (10 ng/ml) to serum-free organoid culture media, and measured the size of the organoids and mRNA expression levels. When we measured the organoids’ size, we viewed 10 fields of each well by the original magnification of 100X. 3 replicates was performed per group, and the software we used was EVOS®XL Core Cell Imaging System (ThermoFisher Scientific) and Microsoft Excel to calculate the average number and size of organoids.

RNA extraction and cRNA microarray analysis

After culturing organoids from mouse gastric corpus infected with H. felis for 12 months or uninfected control, total cellular RNA was extracted from organoid using an acid guanidiumthiocyanate-phenol-chloroform method (ISOGEN Reagents; Nippon Gene, Tokyo, Japan) and column chromatography (RNeasy; Qiagen, Tokyo, Japan), according to the manufacturers’ instructions. Four RNA samples isolated from organoid, two experimental samples originated from mice infected with H. felis and two uninfected mice were used. For microarray analysis, cRNA mouse gene expression microarrays containing 39,430 Entrez Gene RNAs and 16,251 lincRNAs were used according to the manufacturer’s instructions. Genes were considered to be significantly upregulated in organoids infected with H. felis compared to control when they were upregulated in both arrays with an average log2 ratio exceeding 1 (two-fold). The data were confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) analysis using primers (sequences were listed in Table 1).
Table 1

Primer sequences used in this study

Gene name

Forward

Reverse

Gapdh

GAC ATC AAG GTG AAG CAG

ATA CCA GGA AAT GAG CTT GAC AAA

FlaB

TTC GAT TGG TCC TAC AGG CTC AGA

TTC TTG ATG ACA TTG ACC AAC GCA

mIl-1a

GAG CGC TCA AGG AGA CCA G

CAG GTG CAC CCG ACT TTG TTC T

mVillin

GAC GTT TTC ACT GCC AAT ACC A

CCC AAG GCC CTA GTG AAG TCT T

mMuc4

GCT GCC TGT ATT CTT GCC T

ATG TTC TGG TGC TGG A

mCd44

TTG GTC ATA AAA GGG CTC TGT CAA

ATC ACC ACT ATG GCA AGC AAT GTC

mDclk1

GGG AGC CGA TTG TGT TTC AGA A

CTG TTG CCG TCC TGG AGT GTA A

mIl-6

CCG GAG AGG AGA CTT CAC AGA G

CTG CAA GTG CAT CGT TGT T

mIl-1beta

CAA GCA ACG ACA AAA TAC CTG TG

AGA CAA ACC GTT TTT CCA TCT

mTnf-alpha

TGG CCC AGA CCC TCA CAC TCA G

ACC CAT CGG CTG GCA CCA CT

Immunohistochemical analysis

The following antibodies, listed with the catalog number, company, and dilution, were used for immunohistochemical analysis: TFF2 (sc-15,334, Santa Cruz, 1:100), MUC2 (orb13709, Biorbyt, 1:100), DCLK1 (AP7219b, Abgent, 1:100), VILLIN (sc-7672, Santa Cruz, 1:100), CK19 (ab15463, abcam, 1:50), MUC4 (sc-33,654, Santa Cruz, 1:100), CD44v6 (MCA1967, Serotec, 1:100). Immunohistochemical staining was performed on 4 μm sections with avidin-biotin-peroxidase complex kits (Vector Laboratories, USA) and counterstained with hematoxylin. For each mouse, 5 well-oriented gastric glands were scored to quantify the number of positive cells per gland. Data were expressed as average number of positive cells +/− S.D. in each group. Glyceraldehyde 3-phosphate dehydrogenase expression was used as an internal control (GAPDH, Cell Signaling, 2118, 1:1000).

Xenograft tumor model

We first conducted MNU study in male C57BL6/J to generate organoids prior to subcutaneous injection into female NOD/SCID mice. Gastric epithelial cells were isolated and used for organoid culture. After 4 days of culture in Matrigel, we digested Matrigel with Cell Recovery Solution (Corning™ Cat No.354253), collect and centrifuge organoids, and re-suspended in PBS before injection. We injected the organoids subcutaneously into the flanks of 6-week-old female NOD/SCID mice. The sizes of the resulting tumors were measured using a caliper after sacrificing the mice. The tumors were isolated, paraffin-fixed, formalin-embedded, and subjected to histological analysis.

Statistical analysis

Data were expressed as means ± standard error (SE). Differences were analyzed by non-parametric Mann-Whitney U test. A p value less than 0.05 were deemed to indicate statistical significance.

Results

The number of tissue stem/progenitor cells was increased in mouse stomach infected with H. felis

To assess the effect of chronic inflammation on the number of tissue stem/progenitor cells, we used a mouse gastritis model infected with H. felis for up to 12 months (Model 1 in Fig. 1). Histological analysis revealed severe gastric inflammation with lymphoid follicles, neck cell hyperplasia, oxyntic atrophy, and mucous metaplasia (SPEM), particularly in the gastric corpus, as described previously (Fig. 1b) [34]. We performed immunohistochemical analysis of TFF2, MUC2, CD44, DCLK1, and VILLIN, all of which have been proposed to be a tissue stem cell marker in gastrointestinal organs [20, 23, 35]. The expression levels of TFF2, MUC2, CD44, DCLK1, and VILLIN in H. felis-infected mice were significantly higher than those in uninfected control mice (Fig. 1b, c). Most of the cells positive for tissue stem cell markers were likely to be TFF2-positive, suggesting that certain cells in SPEM acquired stem cell properties. Those cells in SPEM also showed a proliferative marker, Ki67-positive (data not shown). These results indicated that chronic inflammation induced by H. felis infection affected the tissue stem cell property, which could be associated with gastric carcinogenesis.

To assess the change in gastric epithelial cells in the stomach after chronic inflammation, we utilized 3D organoid culture systems using cells isolated from mice infected with H. felis, or uninfected controls, as described in Methods. Gastric organoids grew slowly and started to show budding at approximately 10 days after seeding (Fig. 2a). The organoids showed a single-layered epithelial structure under confocal microscopy with E-cadherin immunocytochemistry (data not shown). In accordance with the increased tissue stem/progenitor cells, the number of organoids cultured from H. felis-infected gastric epithelial cells was significantly higher than those from uninfected mice (Fig. 2b). we used half of the stomach for each mouse to establish the organoids. In this experiments, we used five same aged- male mice to generate the organoids.
Fig. 2
Fig. 2

Characterization of gastric organoids established from Helicobacter-infected mouse stomachs. a Scheme and typical features of gastric organoid isolation from mouse gastric corpus. b The number of gastric organoids isolated from mouse gastric corpus, either uninfected or H. felis infected (n = 5 each group). c IL-1α, Villin and Muc4 mRNA expression profiles in organoids isolated from mice gastric corpus infected with H. felis or uninfected (n = 5 each group). d MUC4 protein in gastric mucosa infected with H. felis was detected by immunohistochemistry (original magnification ×200)

mRNA expression profile of organoids established from Helicobacter-infected mouse stomachs

To characterize the organoids in H. felis-infected mouse stomachs, we analyzed the mRNA expression profiles of organoids of the two groups using microarray and qRT-PCR. Among approximately 60,000 spots, 197 genes were up-regulated by two-fold or greater, and 581 genes were down-regulated less than 0.5 times. The top 50 upregulated or downregulated genes are listed in Tables 2, Additional file 1: Table S1 and Table S2. Among these significantly altered genes, intestinal-related genes, such as Isx, Muc4, Muc16 and Villin, were upregulated, whereas gastric-related genes, such as Pepsinogen C and Gif were downregulated, demonstrating that H. felis infection caused intestinal alteration in gastric tissue stem/progenitor cells in vivo. Among the upregulated genes, we focused on genes reported to be associated with gastric carcinogenesis or genes known as stem cell marker, and confirmed that interleukin-1α, Villin and Muc4 expression levels were increased in organoids isolated from H. felis-infected mice compared with control mice by real-time qRT-PCR analysis. (Fig. 2c, Table 2).
Table 2

List of representative genes differentially expressed between organoids with and without H. felis infection

Gene Name

Log2 ratio

Intestine related genes

Isx

2.75

Muc4

2.10

Muc16

1.70

Vil1

1.10

Gastric genes

Pepsinogen C

− 3.17

Gif

− 2.47

Others

Gastrin

3.30

Cd34

2.77

Il-1a

2.51

Cd274 (Pd-l1)

1.31

Muc4, an intestinal mucin, has been shown to be associated with gastric carcinogenesis [3639]. Because Muc4 was upregulated in organoids obtained from H. felis-infected mice, we performed immunohistochemistry analysis to confirm whether MUC4 was expressed in mouse stomachs infected with H. felis. MUC4 protein was expressed in gastric mucosa after 3 months of H. felis infection; furthermore, the area of MUC4-positive mucosa expanded as infection continued (Fig. 2d).

Eradication of H. felis alters mRNA expression profile in organoids

Since early eradication of Helicobacter inhibits gastric cancer progression [31], we analyzed the effect of H. felis eradication on the gene expression profile of gastric organoids. Eradication of H. felis was confirmed by flaB gene expression in gastric tissue at sacrifice (Fig. 3a). The mice were sacrificed and the stomachs were used for immunohistochemical analysis or isolation for 3D–organoid culture as described above. The protein expression of candidate gastric cancer stem/progenitor cells was assessed by using immunohistochemistry. Among the markers analyzed, the number of cells positive for Cd44, Dclk1, Muc4, or Villin was significantly reduced after eradication of H. felis (Fig. 3b). The number of organoids was also significantly reduced after H. felis eradication whereas the size of organoid was not decreased after H. felis eradication (Fig. 3c). We also assessed the mRNA expression of the stem cell markers above in organoid, and found that after H. felis eradication, all markers except Villin, were significantly down-regulated (Fig. 3d), suggesting that H. felis-induced SPEM or intestinal phenotype were reversible by the eradication of H. felis.
Fig. 3
Fig. 3

Eradication of Helicobacter infection alters the gastric tissue stem/progenitor cell marker profile. a Confirmation of infection status of H. felis. FlaB gene was amplified by PCR, and evaluated by gel electrophoresis. Lanes1,2; uninfected, lanes 3,4; infected, and lanes 5,6; eradicated mice. b, c Immunohistochemistry for tissue stem/progenitor cell markers. The number of cells positive for VILLIN, MUC4, and DCLK1 decreased after H. felis eradication. d, e Representative photographs of organoid from each group and the number of organoid in different status of H. felis infection (4 days after isolation, graph bars showed the average number of organoid in high power field. Values were average +/− S.E.). f mRNA expression profiles of tissue stem/progenitor cell markers in organoid

Inflammatory cytokines induced the expression of stem cell markers

Chronic inflammation induced by Helicobacter infection is considered as a key factor in gastric carcinogenesis [40]. When we measured inflammatory cytokines in the organoids generated from each mouse before and after H. felis eradication, all four pro-inflammatory cytokines were increased in the organoid isolated from H. felis infected mice, and downregulated after eradication of H. felis (Fig. 4a). To further analyze the effect of inflammatory cytokines on gastric tissue stem/progenitor cells, we used the organoid culture system to determine whether inflammatory cytokines directly affected the phenotype or mRNA expression profile of gastric organoids. The mRNA levels of Villin, IL-1α, Muc4, and Dclk1 were upregulated in organoids stimulated with inflammatory cytokines compared with untreated organoids. TNF-α administration demonstrated modest up-regulation of those four genes (Fig. 4b). On the other hands, stimulation with IL-1β resulted in marked upregulation of these genes (Fig. 4c). Immunostaining of organoids with an antibody against DCLK1 demonstrated that the number of DCLK1-positive cells was increased in organoids obtained from H. felis-infected stomachs (Fig. 4d). In addition, administration of each cytokine increased the size of organoid (Fig. 4e), suggesting that cytokine stimulation may play a role in inducing a genetic throwback from matured cell to the tissue stem/progenitor cell phenotype through the induction of stem/progenitor cell associated genes, which in turn accelerating their proliferation [4144].
Fig. 4
Fig. 4

Cytokine profile of organoids isolated from mice stomach. a Cytokine profile of organoids isolated from uninfected, H. felis-infected, or eradicated mice gastric corpus. Values were relative mRNA expression +/− S.E. b, c mRNA expression profiles in wild-type mice gastric organoids 6 h after stimulation with cytokines. mRNA expression of putative tissue stem cell markers was increased in organoids after stimulation with pro-inflammatory cytokines. d Confocal micrograph of mouse gastric organoids. Immunocytochemical staining using an antibody against the putative tissue stem cell marker DCLK1 (green). 4′,6-Diamidino-2-phenylindole was used for counterstaining of nuclei. Scale bar: 20 μm. e The size of organoids after stimulation with each cytokine for 3 days

Tumorigenic properties of organoids isolated from mouse stomachs

Finally, we assessed the tumorigenic property of organoids cultured from stomach using NOD/SCID mice. At day 4 of organoid culture, the organoids from MNU-treated mice showed early proliferation of cells, and exhibited an irregular morphology compared with those isolated from H. felis-infected or uninfected mice (Additional file 1: Figure S1A). After 2 months of injection of organoids into NOD/SCID, only organoids from MNU-treated mice produced tumors, and no tumors developed with organoids obtained from mice infected with H. felis or control mice (Additional file 1: Figure S1B). We confirmed that these tumors contained epithelial cells by using CK19 immunohistochemical staining (Additional file 1: Figure S1C). These results suggested that chronic inflammation alone may not be sufficient to induce malignant transformation in gastric tissue stem/progenitor cells, and other factors such as additional genetic/epigenetic changes in tissue stem/progenitor cells would be required for carcinogenesis.

Discussion

In the present study, we demonstrated that chronic inflammation induced by Helicobacter infection caused the alteration in the mRNA/protein expression profile of organoids isolated from mouse stomachs. Muc4, an intestinal mucin protein, was upregulated in both gastric epithelium and organoids obtained from stomachs infected with H. felis. Moreover, expression levels of stem/progenitor cell markers such as Cd44, Dclk1, Muc4 and Villin as well as cytokines were transiently increased after H. felis infection and decreased after the eradication of H. felis. Finally, we demonstrated that the organoids isolated from MNU-treated mice could develop tumors in NOD/SCID mice, whereas no tumors developed from control organoids.

Organotypic culture of the stomach and other tissue has been reported recently, particularly for regenerative medicine and cancer research [45, 46]. Although maintaining growth in primary cultures of epithelial cells is problematic [47], Barker et al. was successful using a 3D Matrigel culture technique with serum-free media. The advantage of organoid culture is analysis of cells without any contamination of non-epithelial cells such as inflammatory cells or stromal fibroblasts. Although tissue stem cell markers in the gastric corpus have not yet been elucidated, we and others have successfully established organoids from mouse stomachs infected with Helicobacter [48]. This technique enables recapitulation of the in vivo status of epithelial cells, enabling the investigation of the mechanisms underlying gastric atrophy, intestinal metaplasia, and carcinogenesis.

Chronic inflammation is known to play key roles in inflammation-associated cancer [40]. Long-term Helicobacter infection can cause oxyntic atrophy, intestinal metaplasia, and cancer; however, the precise mechanism by which inflammation causes cancer remains to be elucidated. Upon Helicobacter infection, gastric epithelial cells produce inflammatory cytokines, such as IL-8, and inflammatory cells recruited from the bone marrow accelerate the inflammatory reaction by producing TNF-α or IL-1β [34, 49, 50]. In the current study, we found that these cytokines were up-regulated in organoids obtained from stomachs infected with chronic Helicobacter infection. Furthermore, administration of these cytokines on organoids resulted in up-regulation of stem/progenitor cell markers, and promoted cell proliferation in vitro. These findings will strongly imply the connection between chronic inflammation and gastric carcinogenesis.

Many genes have been reported to be expressed in cancer-initiating cells, and targeting these cells could facilitate elimination of cancer cells [51]. Cd44 is one of the most reliable marker for targeting gastric cancer [18], and elimination of CD44-positive cells using sulfasalazine plus cisplatin in patients with advanced gastric cancer has been attempted. In our data, Cd44 mRNA was not detected in gastric corpus; however, in the antrum, it was increased in gastric epithelial cells in MNU-induced tumors. Targeting CD44-positive cells should be tested in gastric cancer animal model to evaluate its therapeutic potential for cancer.

Intestinal phenotype called SPEM in stomach has long time been considered as pre-cancerous lesion in gastric carcinogenesis [10]. In the current study, we found that many genes associated with intestinal phenotype were up-regulated in organoid isolated from Helicobacter infected gastric mucosa. In IHC staining, TFF2 and MUC2 were both positive in epithelial cells after chronic Helicobacter infection. Among those genes, Intestine specific homeobox gene, Isx, was up-regulated in Helicobacter-infected organoid. We have already reported that ISX could induce intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis [52]. In humans, eradication of H. pylori could lead the reduction of gastric carcinogenesis [6], however not all gastric cancer was eliminated after H. pylori eradication. Since Intestinal metaplasia has not been completely disappeared after H. pylori eradication, acquisition of stemness or metaplastic phenotype after chronic inflammation through the genetic/epigenetic changes in gastric tissue stem cells could have strong influence in gastric carcinogenesis [41]. Collectively, intestinal phenotype in stomach would be not just a differentiated metaplasia in stomach, but as a phenotype of stem cell abnormality with precancerous lesion susceptible to gastric carcinogenesis after chronic inflammation.

Conclusions

In summary, we demonstrated here that, as one of the possible mechanisms of gastric carcinogenesis, chronic inflammation induced by Helicobacter infection can increase the number of tissue stem/progenitor cells, promote the proliferation of those cells, and alter the properties of stem cells toward intestinal metaplasia to cancer. An organoid culture system combined with a Helicobacter-infected gastric cancer model and xenograft model would enable to identify cancer-initiating cells and investigation of inflammation-associated gastric carcinogenesis. Using this organoid system with primary gastric cells from patients would serve as not only a tool for basic cancer research but also serve as a tool for drug screening in cancer therapy to implement personalized medicine in the future.

Notes

Abbreviations

H. felis

Helicobacter felis

H. pylori

Helicobacter pylori;

IL: 

Interleukin

MNU: 

N-methyl-N-nitroso-urea

PBS: 

phosphate-buffered saline

qRT-PCR: 

quantitative real-time polymerase chain reaction

SE: 

Standard error

SPEM: 

Spasmolytic polypeptide-expressing metaplasia

TFF: 

Trefoil factor

TNF: 

Tumor necrosis factor

Declarations

Acknowledgements

We thank Y. Kubushiro, Y. Yamashita, and A. Miura for their technical assistance.

Funding

This work was supported by JSPS KAKENHI Grant Number 24790715 (SM and WS). The funders had no role in this study, or preparation of this manuscript.

Availability of data and materials

All data were included in the main text and supplementary materials.

Authors’ contributions

SM conceived of the study, SM, WS, SS, ST and YI participated in the design of the study and performed the experiments and statistical analysis. TS, EK, MS, HY, HK, TS, TI, TT and MK participated in the discussion, coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

No human participants were included in this study. All animal studies were approved by Institutional Animal Experiment Committee at Yokohama City University (Approved#; F-A-14-043).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
(2)
Division of Translational Research, Advanced Medical Research Center, Yokohama City University, Yokohama, Japan
(3)
School of Medicine, Yokohama City University, Yokohama, Japan

References

  1. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest. 2007;117(1):60–9.View ArticlePubMedGoogle Scholar
  2. Maeda S, Kanai F, Ogura K, Yoshida H, Ikenoue T, Takahashi M, Kawabe T, Shiratori Y, Omata M. High seropositivity of anti-CagA antibody in helicobacter pylori-infected patients irrelevant to peptic ulcers and normal mucosa in Japan. Dig Dis Sci. 1997;42(9):1841–7.View ArticlePubMedGoogle Scholar
  3. Hirata Y, Maeda S, Mitsuno Y, Tateishi K, Yanai A, Akanuma M, Yoshida H, Kawabe T, Shiratori Y, Omata M. Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. Gastroenterology. 2002;123(6):1962–71.View ArticlePubMedGoogle Scholar
  4. Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A, Mitsuno Y, Yamaji Y, Okamoto M, Yoshida H, et al. CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model. J Pathol. 2006;210(3):306–14.View ArticlePubMedGoogle Scholar
  5. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345(11):784–9.View ArticlePubMedGoogle Scholar
  6. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M. Effect of eradication of helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372(9636):392–7.View ArticlePubMedGoogle Scholar
  7. Ogura K, Hirata Y, Yanai A, Shibata W, Ohmae T, Mitsuno Y, Maeda S, Watabe H, Yamaji Y, Okamoto M, et al. The effect of helicobacter pylori eradication on reducing the incidence of gastric cancer. J Clin Gastroenterol. 2008;42(3):279–83.PubMedGoogle Scholar
  8. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol. 2000;95(6):1431–8.View ArticlePubMedGoogle Scholar
  9. Sakitani K, Hirata Y, Watabe H, Yamada A, Sugimoto T, Yamaji Y, Yoshida H, Maeda S, Omata M, Koike K. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol. 2011;26(10):1570–5.View ArticlePubMedGoogle Scholar
  10. Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA, Goldenring JR. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Investig. 1999;79(6):639–46.PubMedGoogle Scholar
  11. Qiao XT, Gumucio DL. Current molecular markers for gastric progenitor cells and gastric cancer stem cells. J Gastroenterol. 2011;46(7):855–65.View ArticlePubMedGoogle Scholar
  12. Weis VG, Goldenring JR. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer. 2009;12(4):189–97.View ArticlePubMedGoogle Scholar
  13. Weis VG, Sousa JF, LaFleur BJ, Nam KT, Weis JA, Finke PE, Ameen NA, Fox JG, Goldenring JR. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression. Gut. 2013;62(9):1270–9.View ArticlePubMedGoogle Scholar
  14. Visvader JE. Cells of origin in cancer. Nature. 2011;469(7330):314–22.View ArticlePubMedGoogle Scholar
  15. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006;12(10):1167–74.View ArticlePubMedGoogle Scholar
  16. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27(5):1006–20.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Ishimoto T, Oshima H, Oshima M, Kai K, Torii R, Masuko T, Baba H, Saya H, Nagano O. CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci. 2010;101(3):673–8.View ArticlePubMedGoogle Scholar
  18. Wada T, Ishimoto T, Seishima R, Tsuchihashi K, Yoshikawa M, Oshima H, Oshima M, Masuko T, Wright NA, Furuhashi S, et al. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia. Cancer Sci. 2013;104(10):1323–9.View ArticlePubMedGoogle Scholar
  19. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G, et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 2013;152(1–2):25–38.View ArticlePubMedGoogle Scholar
  20. Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, Gumucio DL. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterol. 2007;133(6):1989–98.View ArticleGoogle Scholar
  21. Barker N, van Es JH, Kuipers J, Kujala P. Van den born M, Cozijnsen M, Haegebarth a, Korving J, Begthel H, Peters PJ et al: identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003–7.View ArticlePubMedGoogle Scholar
  22. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H. Van den born M et al: Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010;6(1):25–36.View ArticlePubMedGoogle Scholar
  23. Arnold K, Sarkar A, Yram MA, Polo JM, Bronson R, Sengupta S, Seandel M, Geijsen N, Hochedlinger K. Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell. 2011;9(4):317–29.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Stange DE, Koo BK, Huch M, Sibbel G, Basak O, Lyubimova A, Kujala P, Bartfeld S, Koster J, Geahlen JH, et al. Differentiated troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell. 2013;155(2):357–68.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, Vries R, Peters PJ, Clevers H. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology. 2015;148(1):126–36. e126View ArticlePubMedGoogle Scholar
  26. Yui S, Nakamura T, Sato T, Nemoto Y, Mizutani T, Zheng X, Ichinose S, Nagaishi T, Okamoto R, Tsuchiya K, et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell. Nat Med. 2012;18(4):618–23.View ArticlePubMedGoogle Scholar
  27. Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, Van den born M, Barker N, Shroyer NF, van de Wetering M, Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469(7330):415–8.Google Scholar
  28. Hayakawa Y, Fox JG, Gonda T, Worthley DL, Muthupalani S, Wang TC. Mouse models of gastric cancer. Cancers. 2013;5(1):92–130.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Shibata W, Maeda S, Hikiba Y, Yanai A, Sakamoto K, Nakagawa H, Ogura K, Karin M, Omata M. C-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice. Cancer Res. 2008;68(13):5031–9.View ArticlePubMedGoogle Scholar
  30. Paster BJ, Lee A, Fox JG, Dewhirst FE, Tordoff LA, Fraser GJ, O'Rourke JL, Taylor NS, Ferrero R. Phylogeny of helicobacter felis sp. nov., helicobacter mustelae, and related bacteria. Int J Syst Bacteriol. 1991;41(1):31–8.View ArticlePubMedGoogle Scholar
  31. Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology. 2005;128(7):1937–52.View ArticlePubMedGoogle Scholar
  32. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, et al. Nod1 responds to peptidoglycan delivered by the helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5(11):1166–74.View ArticlePubMedGoogle Scholar
  33. Sato T, Clevers H. Primary mouse small intestinal epithelial cell cultures. Methods Mol Biol. 2013;945:319–28.View ArticlePubMedGoogle Scholar
  34. Shibata W, Takaishi S, Muthupalani S, Pritchard DM, Whary MT, Rogers AB, Fox JG, Betz KS, Kaestner KH, Karin M, et al. Conditional deletion of IkappaB-kinase-beta accelerates helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology. 2010;138(3):1022–1034 e1021-1010.View ArticlePubMedGoogle Scholar
  35. May R, Riehl TE, Hunt C, Sureban SM, Anant S, Houchen CW. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells. 2008;26(3):630–7.View ArticlePubMedGoogle Scholar
  36. Tamura Y, Higashi M, Kitamoto S, Yokoyama S, Osako M, Horinouchi M, Shimizu T, Tabata M, Batra SK, Goto M, et al. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer. PLoS One. 2012;7(11):e49251.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Mejias-Luque R, Linden SK, Garrido M, Tye H, Najdovska M, Jenkins BJ, Iglesias M, Ernst M, de Bolos C. Inflammation modulates the expression of the intestinal mucins MUC2 and MUC4 in gastric tumors. Oncogene. 2010;29(12):1753–62.View ArticlePubMedGoogle Scholar
  38. Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W, Roy HK, Batra SK. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer. 2008;99(6):949–56.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Mejias-Luque R, Peiro S, Vincent A, Van Seuningen I, de Bolos C. IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines. Biochim Biophys Acta. 2008;1783(10):1728–36.View ArticlePubMedGoogle Scholar
  40. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14(5):408–19.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Fujii Y, Yoshihashi K, Suzuki H, Tsutsumi S, Mutoh H, Maeda S, Yamagata Y, Seto Y, Aburatani H, Hatakeyama M. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc Nat Acad Sci USA. 2012;109(50):20584–9.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Cabillic F, Corlu A. Regulation of Transdifferentiation and Retrodifferentiation by inflammatory cytokines in Hepatocellular carcinoma. Gastroenterology. 2016;151(4):607–15.View ArticlePubMedGoogle Scholar
  43. Dubois-Pot-Schneider H, Fekir K, Coulouarn C, Glaise D, Aninat C, Jarnouen K, Le Guevel R, Kubo T, Ishida S, Morel F, et al. Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells. Hepatology. 2014;60(6):2077–90.View ArticlePubMedGoogle Scholar
  44. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704–15.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Barker N, Rookmaaker MB, Kujala P, Ng A, Leushacke M, Snippert H, van de Wetering M, Tan S, Van EJH, Huch M, et al. Lgr5(+ve) stem/progenitor cells contribute to nephron formation during kidney development. Cell Rep. 2012;2(3):540–52.View ArticlePubMedGoogle Scholar
  46. Matano M, Date S, Shimokawa M, Takano A, Fujii M, Ohta Y, Watanabe T, Kanai T, Sato T. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nat Med. 2015;21(3):256–62.View ArticlePubMedGoogle Scholar
  47. Takahashi M, Ota S, Terano A, Yoshiura K, Matsumura M, Niwa Y, Kawabe T, Nakamura T, Omata M. Hepatocyte growth factor induces mitogenic reaction to the rabbit gastric epithelial cells in primary culture. Biochem Biophys Res Commun. 1993;191(2):528–34.View ArticlePubMedGoogle Scholar
  48. Schlaermann P, Toelle B, Berger H, Schmidt SC, Glanemann M, Ordemann J, Bartfeld S, Mollenkopf HJ, Meyer TF. A novel human gastric primary cell culture system for modelling helicobacter pylori infection in vitro. Gut. 2016;65(2):202-13.Google Scholar
  49. Ogura K, Takahashi M, Maeda S, Ikenoue T, Kanai F, Yoshida H, Shiratori Y, Mori K, Mafune KI, Omata M. Interleukin-8 production in primary cultures of human gastric epithelial cells induced by helicobacter pylori. Digestive Dis Sci. 1998;43(12):2738–43.View ArticleGoogle Scholar
  50. Keates S, Hitti YS, Upton M, Kelly CP. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology. 1997;113(4):1099–109.View ArticlePubMedGoogle Scholar
  51. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(−) and thereby promotes tumor growth. Cancer Cell. 2011;19(3):387–400.View ArticlePubMedGoogle Scholar
  52. Sue S, Shibata W, Kameta E, Sato T, Ishii Y, Kaneko H, Miwa H, Sasaki T, Tamura T, Kondo M, et al. Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis. J Gastroenterol. 2016;51(10):949–60.View ArticlePubMedGoogle Scholar

Copyright

Advertisement